After intraperitoneal or intravenous administration of MV-NIS in ovarian cancer or multiple myeloma patients, respectively, positive SPECT/CT scans indicated viral gene expression at the tumor site in a subset of patients [25, 26]. The gene discussed is SLC5A5; the disease is neoplasm.